2,4-dinitrobenzenesulfonic acid has been researched along with oxazolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marcinkiewicz, J; Ptak, W; Rewicka, M; Rózycka, D | 1 |
| Fernando, MR; Graepel, R; Leung, G; McKay, DM; Reyes, JL; Sigvardsson, M; van Rooijen, N; Wang, A | 1 |
2 other study(ies) available for 2,4-dinitrobenzenesulfonic acid and oxazolone
| Article | Year |
|---|---|
The requirement for T lymphocyte-specific suppressor factors and corresponding antigen in the production of nonspecific suppressor monokines by macrophages.
Topics: Animals; Antigens; Benzenesulfonates; Contact Inhibition; Dinitrobenzenes; Dinitrofluorobenzene; Female; Haptens; Lymphokines; Macrophage Migration-Inhibitory Factors; Male; Mice; Oxazolone; Suppressor Factors, Immunologic; T-Lymphocytes; Trinitrobenzenes; Trinitrobenzenesulfonic Acid | 1980 |
Splenic B cells from Hymenolepis diminuta-infected mice ameliorate colitis independent of T cells and via cooperation with macrophages.
Topics: Animals; Antigens, CD19; Antigens, CD1d; B-Lymphocytes; Benzenesulfonates; CD40 Antigens; CD5 Antigens; Colitis; Dextran Sulfate; Homeodomain Proteins; Hymenolepiasis; Hymenolepis diminuta; Immunomodulation; Immunotherapy; Interleukin-10; Interleukin-4; Lipopolysaccharides; Macrophages; Male; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Oxazolone; Receptors, IgE; Th1 Cells; Th2 Cells; Transforming Growth Factor beta | 2015 |